key: cord-0778683-ke189bpa authors: Haqiqi, Ala; Samuels, Theophilus Luke; Lamb, Fiona Jillian; Moharrum, Tamir; Myers, Alice Elizabeth title: Acute haemorrhagic leukoencephalitis (Hurst Disease) in Severe COVID- 19 Infection date: 2021-01-23 journal: Brain Behav Immun Health DOI: 10.1016/j.bbih.2021.100208 sha: a3c513ca2a6c30041d7abfc17d6bf1919bf58b13 doc_id: 778683 cord_uid: ke189bpa Coronavirus Disease 2019 (COVID-19) is well documented as a cause of respiratory tract infection. Increasingly, multi-systemic effects, including COVID-19-related neurologic features, are being reported. Here we report, what we believe to be, the first reported case of acute haemorrhagic leukoencephalitis (AHLE) with presence of oligoclonal bands in the cerebrospinal fluid. AHLE is a rare fulminant demyelinating disease, associated with severe COVID-19 infection. By January 2021, more than 89 million cases of Covid- 19 have been reported worldwide resulting in more than 1 million death 1 3 . This report describes a rare case of acute haemorrhagic leukoencephalitis (AHLE), also known as Hurst disease in a patient with severe COVID-19 requiring invasive ventilation. Oligoclonal bands were identified on cerebrospinal fluid analysis suggesting intra-thecal immune response. A First Computed Tomography (CT) scan of the head (figure 1). (diffuse white matter hypodensity which possibly due to oedema, and multiple bilateral white matter haemorrhagic foci involving the corpus callosum with fluid blood level in some of them, with most of the blood is along the white matter venules). Due to slow weaning from respiratory support and a persistently reduced GCS, tracheostomy was performed on day 20. Anticoagulation was continued. There was no neurosurgical treatment available in this case and no specific treatments were trialled during management. Overall clinical management strategy remained supportive and the patient developed no new problems. By day 49, his GCS remained around 7 (E4VTM3), and he was discharged from ICU to a general respiratory ward. The tracheostomy remained in situ to aid with respiratory secretion management with no supplemental oxygen required. J o u r n a l P r e -p r o o f The MRI findings were still compatible with haemorrhagic leukoencephalitis. The appearances were less marked in comparison with the initial MRI. It also illustrated evidence of leukoencephalitis involving the cerebellum and the pons, with no evidence of haemorrhage within them ( figure 2 ). An electroencephalography (EEG) as follow-up on day 65 was performed. EEG was diffusely slow and poorly responsive in keeping with a diffuse encephalopathy or encephalitis with no epileptiform discharge. Following discharge from ICU, his neurological condition has remained stable with no obvious progression of AHLE. He was also decannulated prior to his discharge from the hospital and remained stable with no oxygen requirement. Despite his prognosis remaining uncertain, the patient was discharged to a neurorehabilitation centre. 3. The platform was Brighton-m2000 Realtime System (Abbott). The COVID assay detects RdRp and N genes with an internal control running alongside to ensure amplification of the target genes occurs. This specimen was tested in Viasure NCO2 assay to detect ORF1ab and N-gene, and also in parallel WHO E-gene assay. The patient was escorted by the anaesthetics team to the MRI scanner room. Following the imaging scan, the MRI scanner is decontaminated according to the trust guideline. The scans were reported by the trust radiologists. Increased symmetrical FLAIR signal throughout the white matter. Diffuse haemosiderin staining throughout the white matter and the genu of the corpus callosum. There are also some cystic haemorrhagic areas containing a fluid-blood level within both cerebral hemispheres. There are some areas of restricted diffusion within the white matter, but this signal change is unreliable owing to the presence of acute haemorrhage. Extensive abnormal signal throughout the white matter bilaterally with haemorrhage compatible with haemorrhagic leukoencephalitis. the appearances are slightly less marked compared with the previous examination. There is evidence of leukoencephalitis involving the cerebellum and the pons, though there is no evidence of haemorrhage within the pons or cerebellum. Disturbance of consciousness has been reported in around 15% of severe COVID-19 cases according to Mao, et al 4 include a direct neurotropic element of the disease or the secondary consequence of cytokine storm 6 . In our case, AHLE is presumed to be the direct complication of severe COVID-19 infection. AHLE is a rare demyelinating condition with significant associated mortality 7 . It AHLE is thought to has previously been reported as a complication of other viral illnesses 8 . be the most fulminant variant of acute disseminated encephalomyelitis (ADEM) with rapid progression of white matter inflammation 9 . In our case, the distribution of the white matter disease on imaging scan matches the ADEM distribution, as it usually involves the subcortical and deep white matter. In severe cases, the brainstem and cerebellum could be involved. Although the haemorrhagic component of AHLE is usually small, we believe in our case, this was severe enough to be depicted by CT due to possible aggravation effects of anticoagulation and hypertension. The pathophysiology of AHLE is not known but cross reactivation of host myelin and viral antigens is thought to be one possible mechanism 7, 8, 10 . Moreover, reported cases of COVID-19 related diffuse leukoencephalopathy and microhaemorrhages have been thought to be likely in association with hypoxaemia 11 . here has been a report of presumed diagnosis of delayed post-hypoxic Although, t leukoencephalopathy (DPHL) 12 following acute respiratory failure in a COVID-19 patient, after the initial period, our patient's oxygenation remained stable during his ICU admission and his MRI findings were in keeping with AHLE. 13 . However, ICH incidence in COVID-19 is lower than ischemic stroke, with only 0.7% incidence 13 . It has been shown that ICH in COVID-19 could be linked with anticoagulation treatment. More than half of these patients were on anticoagulation due to significantly high D-dimer levels, and a larger number of ICH patients were on heparin (treatment dose) 14 . It is speculated that could be rather a sign of severity of the illness than the increased risk of ICH while on heparin infusion 14 . In addition, a reduced 28-day mortality in severe COVID-19 patients (with a significant Ddimer elevation) who were on anticoagulation therapy has been illustrated 15 . It is postulated that anticoagulation treatment of severe COVID-19 patients with significant rise in D-dimer could be beneficial 15 . The use of anticoagulation therapy in severe COVID-19 patients remains controversial. Further studies are required, and individual risk-benefit assessment should be considered. In our case, in view of considerable raised D-dimer and fibrinogen (maximum of 19.23 ug/mL in D-dimer prior to the start of heparin infusion), treatment dose anticoagulation was started as per local guideline. ICH could be thought as a differential diagnosis for such patient population with risk factors (including hypertension, and anticoagulation). However, there were signs of altered mental status in this case, since day 15 (during sedation withdrawal). This was before significant hypertensive episodes occurred. Within 72 hours of the first imaging scan, the D-dimer and fibrinogen were still high (Ddimer mean: 6.23 ug/mL, Fibrinogen mean: 6.02 g/L), with APTT ratio in target range between 1.5-2.5, and normal platelet level during his admission. The small vessel white matter disease is usually evident in hypertensive cerebrovascular disease imaging, and if the haemorrhage occurs, it is most frequently seen in basal ganglia followed by thalamus, brain stem and cerebellum (all are spared in our case). 10% of hypertensive haemorrhage can be lobar, but this incidence is controversial, because older hypertension patients may also have amyloid angiopathy. Hypertension and anticoagulation in our case, are thought to have aggravated the bleeding rather than caused it. Furthermore, hypertensive micro-bleeds are encountered in the deep grey matter and posterior fossa more than subcortically. Other differential diagnosis could be posterior reversible encephalopathy syndrome, which usually involves the cortex and subcortical white matter with no preservation of the subcortical U-fibres. In our case, the radiological findings are suggestive of the diagnosis of AHLE with diffuse white matter involvement, foci of haemorrhages, surrounding oedema, subcortical U-fibres, and cortical sparing. In contrast, in one study looking at haemorrhagic stroke in Covid-19, the punctuate haemorrhages of parenchymal bleeding were usually found to involve the cortices 16 . Imaging scans play a crucial role in the early identification of AHLE. MRI could also differentiate AHLE from ADEM through demonstrating the presence of petechial haemorrhages and extensive white matter lesions in AHLE 17 . Another differential diagnosis of AHLE could be infectious encephalitis. In HSV-1, brain involvement is often in temporal and limbic areas 17 18 where the patient presented with altered conscious level and no abnormal findings on CSF analysis 18 . In our case, no focal neurological features were noted at presentation but high opening pressure at lumbar puncture, high CSF protein, and serum and CSF oligoclonal bands with additional bands in CSF were identified. Furthermore, a fatal case of ANE in COVID-19 has been reported. However, no oligoclonal bands were identified in their CSF analysis. The CT head showed brain oedema, whereas our case's CT head showed multiple bilateral white matter haemorrhagic foci involving the corpus callosum as well as oedema 19 . Although the AHLE diagnosis is usually confirmed at autopsy and biopsy 8 , MRI characteristics are useful in early detection of the condition. MRI findings show multifocal lesions 8, 18 . Susceptibility weighted sequences demonstrate haemorrhage. There is white matter signal alteration with sparing of the grey matter, in a predominantly frontoparietal distribution. The Basal ganglia, brain stem and spinal cord may also be affected 8 . Some have suggested a potential role for corticosteroids or intravenous immunoglobulin as treatment 18, 20, 21 . These were not considered viable options in this case due to the risks of ongoing infection. Oligoclonal bands which are common to both CSF and serum imply a systemic inflammatory response, whilst bands which are restricted to the CSF suggest an additional specific central nervous system (CNS) response. Drouet et al. reported a case of borrelia burgdorferi infection related leukoencephalopathy with oligoclonal Immunoglobulin (Ig) appearance 22 . The SARS-CoV-2 RNA was not detected in the CSF. Due to temporary distribution of SARS-CoV-2 virus in CSF, isolating the virus is challenging 23 . It is postulated that significant immune response could cause damage in the blood brain barrier (BBB) and this may result in CNS inflammation 23, 24 . Oligoclonal IgG in CSF could present in the subacute phase of an infective encephalitis 25 . In our case, although the SARS-CoV-2 PCR was negative in CSF, the presence of additional oligoclonal bands in the CSF may be an indication of an immunologic response to the infection. Repeat MRI head performed at day 60 suggested possible slight improvement of AHLE appearances. This raises the question of whether AHLE in COVID-19 could be self-limiting in the subacute phase. To the best of our knowledge this is the first reported case of AHLE with positive oligoclonal bands associated with SARS-CoV-2 infection to date with follow-up MRI scan and EEG. Further data is essential to establish the causative mechanism, optimal management, and to elucidate the prognosis of this condition associated with COVID-19. COVID-19 Dashboard by the Center for Systems Science and Engineering Neurologic Features in Severe SARS-CoV-2 Infection Neurological complications of coronavirus and COVID-19 Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection Acute Haemorrhagic Leukoencephalitis. Neuropathological Study of One Case Favourable Outcome in a 33-Year-Old Female with Acute Haemorrhagic Leukoencephalitis Acute Hemorrhagic encephalomyelitis (AHEM) Mimicking Abscess (Case of the Week) cute Hemorrhagic Leukoencephalitis Associated With Autoimmune Myopathy COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients Risk factors for intracerebral hemorrhage in patients with COVID-19 Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Hemorrhagic stroke and anticoagulation in COVID-19 Acute Hemorrhagic Leukoencephalitis: A Case and Systematic Review of the Literature COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI features Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19 Neurologic complications of COVID-19 Steroid-responsive Encephalitis in Covid-19 Disease Acute severe leukoencephalitis with posterior lesions due to Borrelia burgdorferi infection Encephalitis as a clinical manifestation of COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System Clinical relevance of polymerase chain reaction (PCR) assays and antigen-driven immunoblots for the diagnosis of neurological infectious diseases Leukoencephalitis (AHLE) could be a neurological complication of severe COVID-19 infection • The presence of oligoclonal bands in the CSF could highlight the central inflammatory response • Here a rare case of AHLE in a severe COVID-19 infection with positive oligoclonal bands in CSF is described We are thankful to our patient's family for giving us permission to report this rare manifestation of the COVID-19. We thank Dr Stephanie Jane Smith for providing the testing details. We thank Dr Jeffery Kimber for his expert neurology opinion. We would like to acknowledge the immense hard work and dedication of our ICU team who were key to make an enormous difference in our patients' disease journey.